Article: TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleTSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma
AuthorsLung, HL
Cheung, AKL
Xie, D4 5
Cheng, Y2
Kwong, FM
Murakami, Y1
Guan, XY4
Sham, JS4
Chua, D4
Protopopov, AI3
Zabarovsky, ER3
Tsao, SW4
Stanbridge, EJ6
Lung, ML7
Issue Date2006
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
CitationCancer Research, 2006, v. 66 n. 19, p. 9385-9392 [How to Cite?]
DOI: http://dx.doi.org/10.1158/0008-5472.CAN-06-0590
AbstractIn up to 87% of nasopharyngeal carcinoma (NPC) clinical tumor specimens, there was either down-regulation or loss of TSLC1 gene expression. Using a tissue microarray and immunohistochemical staining, the frequency of down-regulated or loss of expression of TSLC1 in metastatic lymph node NPC was 83% and the frequency of loss of expression of TSLC1 was 35%, which was significantly higher than that in primary NPC (12%). To examine the possible growth-suppressive activity of TSLC1 in NPC, three NPC cell lines, HONE1, HNE1, and CNE2, were transfected with the wild-type TSLC1 gene cloned into the pCR3.1 expression vector; a reduction of colony formation ability was observed for all three cell lines. A tetracycline-inducible expression vector, pETE-Bsd, was also used to obtain stable transfectants of TSLC1. There was a dramatic difference between colony formation ability in the presence or absence of doxycycline when the gene is shut off or expressed, respectively, with the tetracycline-inducible system. Tumorigenicity assay results show that the activation of TSLC1 suppresses tumor formation in nude mice and functional inactivation of this gene is observed in all the tumors derived from tumorigenic transfectants. Further studies indicate that expression of TSLC1 inhibits HONE1 cell growth in vitro by arresting cells in G 0-G 1 phase in normal culture conditions, whereas in the absence of serum, TSLC1 induced apoptosis. These findings suggest that TSLC1 is a tumor suppressor gene in NPC, which is significantly associated with lymph node metastases. ©2006 American Association for Cancer Research.
ISSN0008-5472
2011 Impact Factor: 7.856
2011 SCImago Journal Rankings: 1.309
DOIhttp://dx.doi.org/10.1158/0008-5472.CAN-06-0590
ISI Accession Number IDWOS:000241014200009
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorLung, HL
dc.contributor.authorCheung, AKL
dc.contributor.authorXie, D
dc.contributor.authorCheng, Y
dc.contributor.authorKwong, FM
dc.contributor.authorMurakami, Y
dc.contributor.authorGuan, XY
dc.contributor.authorSham, JS
dc.contributor.authorChua, D
dc.contributor.authorProtopopov, AI
dc.contributor.authorZabarovsky, ER
dc.contributor.authorTsao, SW
dc.contributor.authorStanbridge, EJ
dc.contributor.authorLung, ML
dc.date.accessioned2010-09-06T05:59:33Z
dc.date.available2010-09-06T05:59:33Z
dc.date.issued2006
dc.description.abstractIn up to 87% of nasopharyngeal carcinoma (NPC) clinical tumor specimens, there was either down-regulation or loss of TSLC1 gene expression. Using a tissue microarray and immunohistochemical staining, the frequency of down-regulated or loss of expression of TSLC1 in metastatic lymph node NPC was 83% and the frequency of loss of expression of TSLC1 was 35%, which was significantly higher than that in primary NPC (12%). To examine the possible growth-suppressive activity of TSLC1 in NPC, three NPC cell lines, HONE1, HNE1, and CNE2, were transfected with the wild-type TSLC1 gene cloned into the pCR3.1 expression vector; a reduction of colony formation ability was observed for all three cell lines. A tetracycline-inducible expression vector, pETE-Bsd, was also used to obtain stable transfectants of TSLC1. There was a dramatic difference between colony formation ability in the presence or absence of doxycycline when the gene is shut off or expressed, respectively, with the tetracycline-inducible system. Tumorigenicity assay results show that the activation of TSLC1 suppresses tumor formation in nude mice and functional inactivation of this gene is observed in all the tumors derived from tumorigenic transfectants. Further studies indicate that expression of TSLC1 inhibits HONE1 cell growth in vitro by arresting cells in G 0-G 1 phase in normal culture conditions, whereas in the absence of serum, TSLC1 induced apoptosis. These findings suggest that TSLC1 is a tumor suppressor gene in NPC, which is significantly associated with lymph node metastases. ©2006 American Association for Cancer Research.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationCancer Research, 2006, v. 66 n. 19, p. 9385-9392 [How to Cite?]
DOI: http://dx.doi.org/10.1158/0008-5472.CAN-06-0590
dc.identifier.doihttp://dx.doi.org/10.1158/0008-5472.CAN-06-0590
dc.identifier.epage9392
dc.identifier.hkuros173231
dc.identifier.isiWOS:000241014200009
dc.identifier.issn0008-5472
2011 Impact Factor: 7.856
2011 SCImago Journal Rankings: 1.309
dc.identifier.issue19
dc.identifier.openurl
dc.identifier.pmid17018592
dc.identifier.scopuseid_2-s2.0-33750331446
dc.identifier.spage9385
dc.identifier.urihttp://hdl.handle.net/10722/67929
dc.identifier.volume66
dc.languageeng
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
dc.publisher.placeUnited States
dc.relation.ispartofCancer Research
dc.relation.referencesReferences in Scopus
dc.subject.meshCarcinoma, Squamous Cell - genetics - pathology - secondary
dc.subject.meshGenes, Tumor Suppressor
dc.subject.meshImmunoglobulins - deficiency - genetics - physiology
dc.subject.meshLymphatic Metastasis - genetics
dc.subject.meshMembrane Proteins - deficiency - genetics - physiology
dc.titleTSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma
dc.typeArticle
Author Affiliations
  1. National Cancer Center Research Institute
  2. National Naval Medical Center
  3. Institutionen För Mikrobiologi, Tumör-Och Cellbiologi
  4. The University of Hong Kong
  5. Sun Yat-Sen University
  6. UC Irvine
  7. Hong Kong University of Science and Technology